Open access
Open access
Powered by Google Translator Translator

FDA approvement of Alzheimer’s drug sparks controversy among doctors.

9 Jun, 2021 | 08:18h | UTC

News release: FDA Grants Accelerated Approval for Alzheimer’s Drug – U.S. Food & Drug Administration

Commentaries: ICER Issues Statement on the FDA’s Approval of Aducanumab for Alzheimer’s Disease – Institute for Clinical and Economic Review AND Landmark Alzheimer’s Drug Approval Confounds Research Community – Nature AND FDA approves Alzheimer’s drug from Biogen, against experts’ advice – NBC News AND F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works – The New York Times (a few articles per month are free) AND Alzheimer’s drug approved despite doubts about effectiveness – Science (a few articles per month are free) AND The FDA Has Approved A New Alzheimer’s Drug — Here’s Why That’s Controversial – NPR AND Opinion: Bad medicine: aducanumab is a lackluster drug with a high price tag – STAT

 


Stay Updated in Your Specialty

No spam, just news.